Kristine B. Patterson

Author

University of North Carolina at Chapel Hill

Also Known As

Allmon, Andrew, Aweeka, Francesca, Cavert, Winston, Cohen, M. S., Dertinger, Stephen D., Drulak, M., Dumond, Julie B, Eron, J. J., Eron, Joseph J., Fedoriw, Yuri

102

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Harvard University University of California, San Francisco Brigham and Women's Hospital Johns Hopkins University

About

Kristine B. Patterson is an author at University of North Carolina at Chapel Hill specializing in medicine, hiv, and sexual health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	403
2	Public Health	5	5	261
3	Social Sciences	2	2	145
4	Health Sciences	1	1	36
5	Nursing	1	1	98

Kristine B. Patterson

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission Kristine B. Patterson, Heather A. Prince, Eric Kraft, Science Translational Medicine	2011	344
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine Mackenzie L. Cottrell, Kuo H. Yang, Heather M. A. Prince, The Journal of Infectious Diseases	2016	294
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1 Jeffrey L. Lennox, Raphael J. Landovitz, Heather J. Ribaudo, Annals of Internal Medicine	2014	255
Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers Rosa F. Yeh, Vincent E. Gaver, Kristine B. Patterson, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	189
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis Julie B. Dumond, Rosa F. Yeh, Kristine B. Patterson, AIDS	2007	178
Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066) Craig W. Hendrix, Adriana Andrade, Namandjé N. Bumpus, AIDS Research and Human Retroviruses	2015	173
Maraviroc Concentrates in the Cervicovaginal Fluid and Vaginal Tissue of HIV-Negative Women Julie B. Dumond, Kristine B. Patterson, Allison L Pecha, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	127
Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188 Mary Vogler, Kristine B. Patterson, Lori Kamemoto, JAIDS Journal of Acquired Immune Deficiency Syndromes	2010	115
Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults Jacob Lalezari, Melanie Thompson, Priny Kumar, AIDS	2005	111
“I Should Know Better”: The Roles of Relationships, Spirituality, Disclosure, Stigma, and Shame for Older Women Living With HIV Seeking Support in the South Catherine A. Grodensky, Carol E. Golin, Chaunetta Jones, Journal of the Association of Nurses in AIDS Care Family MedicineGeriatric MedicineOlder PeopleUnited StatesSocial Support	2014	98

Page 1